DAUNORUBICIN HYDROCHLORIDE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2019-07-16
- Label type
- Indexing - Product Concept
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-05 00:18:29
Label at a glance#
ProductDAUNORUBICIN HYDROCHLORIDE
Active ingredientDAUNORUBICIN HYDROCHLORIDE
Products#
Every source-derived product name is available through these pages.
- DAUNORUBICIN HYDROCHLORIDE
- DAUNORUBICIN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DAUNORUBICIN HYDROCHLORIDE | UD984I04LZ | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daunorubicin Hydrochloride | DAUNORUBICIN HYDROCHLORIDE | Hisun Pharmaceuticals USA, Inc. | 9705fa12-499e-41a3-8fb4-f6df0858b851 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | Daunorubicin Hydrochloride DAUNORUBICIN HYDROCHLORIDE |
| daunorubicin hydrochloride | DAUNORUBICIN HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | ff6b9bd4-8a9f-400f-a0b9-70e25fa8a28f | 2025-05-21 | Boxed warning, Warnings, Adverse reactions | daunorubicin hydrochloride DAUNORUBICIN HYDROCHLORIDE |
| Daunorubicin Hydrochloride | DAUNORUBICIN HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 227784a8-ce68-4dd4-8ac5-a65265969677 | 2024-02-15 | Boxed warning, Warnings, Adverse reactions | Daunorubicin Hydrochloride DAUNORUBICIN HYDROCHLORIDE |
| Daunorubicin Hydrochloride | DAUNORUBICIN HYDROCHLORIDE | Hisun Pharmaceuticals USA, Inc. | f4312095-3c21-296b-e053-2995a90a0d9c | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | Daunorubicin Hydrochloride DAUNORUBICIN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.